Finance Director - FP&A at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Technology, HealthcareIndustries

Requirements

Bachelor's degree in Finance, Accounting, a related field or equivalent directly related work
MBA is preferred; CPA/CMA is a plus
10+ years of experience in relevant Finance roles
Prior experience leading a team, fostering a culture of high performance, continuous improvement, and deep business acumen
Extensive experience with Excel
Expertise with MS Excel and PowerPoint
Familiarity with Netsuite and Datarails is a plus
Excellent analytical skills and the capacity to identify problems and opportunities and to provide well-informed recommendations for solutions
Ability to structure logical, analytical approaches and apply a range of techniques to solve business problems in an efficient, timely manner
Exceptional executive presence and communication skills with a track record of building solid relationships cross-functionally
Excellent verbal, written, and interpersonal communication skills
Curiosity, strong critical thinking skills, and an insatiable appetite for learning
Command of scenario planning and sensitivity analysis to evaluate the impact of various strategic initiatives
Comfortable working in a fast-paced and dynamic environment

Responsibilities

Drive the multi-year strategic planning process across the organization, developing robust financial models that project future performance and evaluate financial returns of various strategic initiatives
Lead the comprehensive development and finalization of the company’s annual budget
Manage timely and accurate quarterly and rolling financial forecasts, identifying key risks and opportunities. Provide in-depth variance analysis of actual results against budget and forecast, explaining drivers of performance to senior management
Prepare executive-level presentations, including materials for the Board of Directors, Executive Leadership Team and Investor Relations, summarizing financial performance, strategic progress, and future outlook
Develop and maintain sophisticated models to monitor and forecast revenue performance by product and geography
Analyze pricing performance, providing recommendations to optimize top-line growth and profitability
Serve as the financial lead for gross margin optimization. Conduct detailed analysis of COGS components, partnering with Operations team to drive structural margin improvements
Create financial models, PowerPoint presentations, and data visualization as required

Skills

FP&A

Financial Modeling

Strategic Planning

Budgeting

Financial Forecasting

Variance Analysis

Valuation Modeling

Long-range Planning

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free